An apple a day to prevent Parkinson disease: Reduction of risk by flavonoids

Neurology

Volumn 78, Issue 15, 2012, Pages 1112-1113

  Kukull, Walter A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DIOSMETIN; FLAVONOID; HESPERETIN; METRONIDAZOLE; MIDAZOLAM; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

APPLE; BLUEBERRY; DIETARY INTAKE; DRUG METABOLISM; DRUG TRANSFORMATION; EDITORIAL; FOOD DRUG INTERACTION; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HUMAN; ORANGE (FRUIT); ORANGE JUICE; PARKINSON DISEASE; PRIORITY JOURNAL; RED WINE; RISK REDUCTION; SEX DIFFERENCE; STRAWBERRY; TEA;

EID: 84860749808     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31824f80e4     Document Type: Editorial

References (12)

1. Bronstein J, Carvey P, Chen H, et al. Meeting report: Consensus statement: Parkinson's disease and the environment: Collaborative on Health and the Environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect 2009;117: 117-121.
2. Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009;41:1308-1312.
3. Hardy J. Genetic analysis of pathways to Parkinson disease. Neuron 2010;68:201-206.
4. Devine MJ, Gwinn K, Singleton A, Hardy J. Parkinson's disease and alpha-synuclein expression. Mov Disord 2011; 26:2160-2168.
5. Volpicelli-Daley LA, Luk KC, Patel TP, et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011;72:57-71.
6. Sato S, Hattori N. Genetic mutations and mitochondrial toxins shed new light on the pathogenesis of Parkinson's disease. Parkinson Dis 2011:979231, 2011.
7. Tanner CM, Kamel F, Ross GW, et al. Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect 2011;119:866-872.
8. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003;18: 19-31. (Pubitemid 36150204)
9. Langston JW, Ballard PA Jr. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 1983;309:310. (Pubitemid 13074924)
10. Gao X, Cassidy A, Schwarzschild MA, Rimm EB, Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology 2012;78:1138-1145.
11. Wauthier V, Verbeeck RK, Calderon PB. The effect of ageing on cytochrome p450 enzymes: Consequences for drug biotransformation in the elderly. Curr Med Chem 2007;14:745-757. (Pubitemid 46477709)
12. Quintieri L, Bortolozzo S, Stragliotto S, et al. Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. Drug Metab Pharmacokinet 2010;25:466-476.